Moreover, MR antagonism is beneficial for preventing cardiac hypertrophy and failure also in hypertensive rat with low aldosterone (35), suggesting that in this particular situation MR is not activated by aldosterone itself but through glucocorticoid binding. The gene discussed is NR3C2; the disease is cardiac hypertrophy.